RANI 241220 5.00P (RANI241220P5000) Stock Options, News & Quotes

US OptionsDetailed Quotes

RANI241220P5000

Watchlist

3.20
0.000.00%

15min DelayTrading Nov 18 13:03 ET

0.00High0.00Low

Intraday

5D
Daily

News

H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9
Moomoo NewsNov 19 06:31 ET · Ratings
Rani Therapeutics Hldgs Analyst Ratings
BenzingaNov 19 06:15 ET · Ratings
Rani Therapeutics Advances in Biotherapeutics Market
TipRanksNov 18 22:54 ET
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Immutep Ltd (OtherPRRUF)
TipRanksNov 17 21:10 ET · Ratings
Maxim Group Remains a Buy on Rani Therapeutics Holdings (RANI)
TipRanksNov 15 15:45 ET · Ratings
Rani Therapeutics' Weight-Loss Drugs Can Serve Specific Needs -- Market Talk
WSJNov 15 11:59 ET

Comments

Darshan Kalirasa

Nov 13 03:40

NVDA market value exceeds $3.6T! Can earnings fuel the stock price further?

TheLongKhan

Oct 22 14:05

$Rani Therapeutics (RANI.US)$ I guess the market doesn't have the sentiment of the analysts

Deadly Antics

Oct 17 08:54

My picks for today

Learn. Trade. Win: Dive into our Global Paper Trading Challenge now!

TheLongKhan

Oct 17 08:27

$Rani Therapeutics (RANI.US)$ go baby go!

Trytosaveabit

Oct 17 07:03

Update

$Rani Therapeutics (RANI.US)$ Reuters· 2 mins ago
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist